Xeris Biopharma Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 May 24 | BuyUS$10,314 | John Schmid | Individual | 5,400 | US$1.91 | |
14 Mar 24 | BuyUS$9,720 | John Schmid | Individual | 4,500 | US$2.16 | |
27 Nov 23 | BuyUS$10,098 | Jeffrey Sherman | Individual | 5,400 | US$1.87 | |
20 Nov 23 | BuyUS$54,600 | Steven Pieper | Individual | 28,000 | US$1.95 | |
20 Nov 23 | BuyUS$9,954 | Dawn Halkuff | Individual | 5,410 | US$1.84 | |
17 Nov 23 | BuyUS$50,400 | John Shannon | Individual | 30,769 | US$1.64 | |
16 Nov 23 | BuyUS$9,815 | John Schmid | Individual | 6,500 | US$1.51 | |
14 Nov 23 | BuyUS$10,058 | Marla Persky | Individual | 6,370 | US$1.58 | |
09 Aug 23 | BuyUS$23,794 | Paul Edick | Individual | 10,000 | US$2.38 |
Insider Trading Volume
Insider Buying: XERS insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,183 | 0.00147% |
Individual Insiders | 4,130,014 | 2.79% |
Institutions | 63,878,693 | 43.1% |
General Public | 80,244,773 | 54.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,960,506 | US$22.1m | -0.51% | no data | |||
7,606,242 | US$16.9m | 7.34% | no data | |||
5,113,348 | US$11.4m | -9.37% | 0.68% | |||
4,166,496 | US$9.2m | 8.3% | 1.34% | |||
3,215,016 | US$7.1m | 18% | no data | |||
3,045,364 | US$6.8m | 5.3% | no data | |||
3,028,755 | US$6.7m | 0% | 0.34% | |||
2,820,170 | US$6.3m | -20.4% | 4.55% | |||
1,695,753 | US$3.8m | 9.55% | no data | |||
1,585,097 | US$3.5m | 278% | no data | |||
1,543,873 | US$3.4m | 1,300% | 0.21% | |||
1,256,698 | US$2.8m | 4.23% | no data | |||
1,161,772 | US$2.6m | -28.4% | no data | |||
1,159,555 | US$2.6m | -0.5% | no data | |||
1,140,275 | US$2.5m | 317% | no data | |||
1,046,587 | US$2.3m | 0% | 0.08% | |||
1,009,340 | US$2.2m | -27% | no data | |||
953,236 | US$2.1m | 83.3% | no data | |||
798,483 | US$1.8m | 12.6% | no data | |||
707,011 | US$1.6m | -33% | no data | |||
625,087 | US$1.4m | 140% | no data | |||
604,512 | US$1.3m | 6.31% | 0.18% | |||
600,000 | US$1.3m | 54.7% | 0.4% | |||
598,086 | US$1.3m | -89.9% | 0.9% | |||
573,186 | US$1.3m | 3.57% | 0.01% |